Mode
Text Size
Log in / Sign up
Phase 3 N=1,000 Randomized Double-blind Treatment

Spinal Manipulation and Patient Self-Management for Preventing Acute to Chronic Back Pain

Acute Pain · Low Back Pain, Mechanical

Enrolled (actual)
1,000
Serious AEs
8.6%
Results posted
Oct 2025
Primary outcome: Primary: Pain Intensity — 2.8; 3.0; 2.8; 3.0 score on a scale — p=0.16

Study Design & Population

Study type
Interventional
Phase
Phase 3
Interventions
Supported-Self Management (SSM) (Behavioral); Spinal Manipulation Therapy (SMT) (Other); SMT + SSM (Combination_product); Standard Medical Care (SMC) (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Minnesota
Primary completion
Jun 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Pain Intensity
2.8; 3.0; 2.8; 3.0 0.16
PRIMARY
Disability
4.7; 5.5; 4.8; 5.9 0.001 sig
PRIMARY
Low Back Pain (LBP) That is Impactful
15.3; 16.7; 15.7; 17.0 0.006 sig
SECONDARY
Recovery From Acute/Sub-acute Low Back Pain
56; 29; 33; 38
SECONDARY
Low Back Pain Frequency - Percent of Days Over 12 Months
39; 44; 38; 46
SECONDARY
Number of Participants Who Received Care For Low Back Pain
82; 67; 53; 128
SECONDARY
Medication Use - Percent of Months 4-12
37; 40; 37; 54
SECONDARY
Bothered by Low Back Pain at Work - Percent of Months
43; 45; 43; 51
SECONDARY
Global Improvement
6.2; 5.8; 6.3; 5.5
SECONDARY
Global Improvement
6.2; 5.8; 6.3; 5.5
SECONDARY
Global Improvement
6.2; 5.8; 6.3; 5.5
SECONDARY
Patient Satisfaction With Treatment
4.7; 4.6; 5.1; 4.0
SECONDARY
Patient Satisfaction With Treatment
4.7; 4.6; 5.1; 4.0
SECONDARY
Patient Satisfaction With Treatment
4.7; 4.6; 5.1; 4.0
SECONDARY
Chronic Low Back Pain (LBP)
93; 93; 68; 151
SECONDARY
Chronic Low Back Pain (LBP)
93; 93; 68; 151
SECONDARY
Number of Participants Who Reported Chronic Interference With Daily Activities
41; 36; 36; 76
SECONDARY
Number of Participants Who Reported Chronic Interference With Daily Activities
41; 36; 36; 76
SECONDARY
Timed Up and Go Test
9.5; 9.5; 9.5; 10.0
SECONDARY
Sit-to-stand
10.5; 11.4; 10.9; 10.9
SECONDARY
The Sock Test
112; 65; 53; 114; 28; 15
SECONDARY
Visual Trajectory for Pain
18; 6; 13; 15; 103; 53
SECONDARY
Quebec Task Force
70; 38; 32; 59; 150; 106
SECONDARY
Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression
50.6; 50.2; 50.8; 50.8; 49.6; 49.0
SECONDARY
Patient-Reported Outcomes Measurement Information System (PROMIS) - Physical Function
40.7; 21.7; 41.3; 40.5; 46.0; 46.8
SECONDARY
Patient-Reported Outcomes Measurement Information System (PROMIS) - Anxiety
53.5; 53.6; 54.2; 53.8; 51.7; 51.2
SECONDARY
Patient-Reported Outcomes Measurement Information System (PROMIS) - Fatigue
55.2; 54.3; 54.8; 55.2; 52.4; 51.2
SECONDARY
Patient-Reported Outcomes Measurement Information System (PROMIS) - Sleep Disturbance
52.0; 51.8; 52.0; 52.1; 52.6; 52.2
SECONDARY
Patient-Reported Outcomes Measurement Information System (PROMIS) - Participation
46.8; 47.7; 47.7; 46.6; 53.2; 53.5
SECONDARY
Patient-Reported Outcomes Measurement Information System (PROMIS) - Pain Interference
60.3; 59.2; 59.9; 60.3; 52.9; 52.0
SECONDARY
STarT Back Risk Classification
243; 158; 157; 226; 34; 23
SECONDARY
STarT Back Risk Classification
243; 158; 157; 226; 34; 23
SECONDARY
STarT Back Risk Classification
243; 158; 157; 226; 34; 23

Summary

This is a study of adults with acute low back pain flare-up at risk of becoming chronic and disabling. The study tests how well spinal manipulation and guided selfcare work compared to standard medical care. The treatments last up to eight weeks and participants will be followed for one year.

Eligibility Criteria

Inclusion Criteria

  • At least 18 years of age
  • Acute or sub-acute low back pain
  • Average low back pain severity ≥3 on the 0-10 numerical rating scale over 7 days
  • Medium or high risk for persistent disabling back pain according to the STarT Back screening tool
  • Ability to read and write fluently in English

Exclusion Criteria

  • Non-mechanical causes of low back pain
  • Contraindications to study treatments (e.g, . surgical fusion of lumbar spine)
  • Active management of current episode of low back pain by another healthcare provider
  • Serious co-morbid health condition that either requires medical attention or has a risk for general health decline over the next year
  • Pregnancy, current or planned during study period and nursing mothers
  • Inability or unwillingness to give written informed consent
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03581123). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search